Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 129.90K | 9.30K | 19.60K | 66.00K | 426.10K |
Total Receivables | 1.54M | 2.53M | 3.76M | 3.82M | 3.70M |
Inventory | 2.32M | 2.10M | 2.64M | 2.90M | 2.20M |
Prepaid Expenses | 684.00K | 492.40K | 625.80K | 377.30K | 510.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00 | 0.00 | -- | -- | 0.00 |
Total Current Assets | 4.68M | 5.13M | 7.04M | 7.17M | 6.84M |
|
|||||
Total Current Assets | 4.68M | 5.13M | 7.04M | 7.17M | 6.84M |
Net Property, Plant & Equipment | 2.20M | 2.32M | 2.41M | 2.48M | 2.45M |
Long-term Investments | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M |
Goodwill | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M |
Total Other Intangibles | 336.30K | 384.00K | 431.70K | 463.50K | 511.10K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 107.10K | 143.80K | 445.20K | 786.00K | 2.33M |
Total Assets | 18.77M | 19.43M | 21.78M | 22.35M | 23.58M |
|
|||||
Total Accounts Payable | 7.54M | 7.19M | 6.97M | 5.98M | 5.86M |
Total Accrued Expenses | 4.81M | 4.05M | 4.02M | 4.43M | 4.16M |
Short-term Debt | 1.65M | 415.00K | 490.00K | 540.00K | 2.37M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.51M | 3.00M | 2.30M | 2.17M | 1.75M |
Total Finance Division Other Current Liabilities | 1.04M | 819.40K | 614.60K | 382.60K | -- |
Total Other Current Liabilities | 1.04M | 819.40K | 614.60K | 382.60K | -- |
Total Current Liabilities | 17.55M | 15.47M | 14.39M | 13.50M | 14.14M |
|
|||||
Total Current Liabilities | 17.55M | 15.47M | 14.39M | 13.50M | 14.14M |
Long-Term Debt | 1.70M | 2.30M | 3.00M | 3.55M | 4.35M |
Short-term Debt | 1.65M | 415.00K | 490.00K | 540.00K | 2.37M |
Capital Leases | 292.60K | 322.90K | 350.80K | 294.10K | 258.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 847.30K |
Total Liabilities | 19.54M | 18.09M | 17.74M | 17.34M | 19.59M |
|
|||||
Common Stock & APIC | 85.41M | 85.28M | 94.29M | 84.80M | 84.00M |
Retained Earnings | -85.03M | -82.79M | -79.98M | -78.65M | -78.94M |
Treasury Stock & Other | -1.98M | -1.98M | -11.10M | -1.98M | -1.91M |
Total Common Equity | -1.60M | 511.90K | 3.21M | 4.17M | 3.16M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 828.00K | 828.00K | 828.00K | 828.00K | 824.80K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 828.00K | 828.00K | 828.00K | 828.00K | 824.80K |
|
|||||
Total Common Equity | -1.60M | 511.90K | 3.21M | 4.17M | 3.16M |
Total Preferred Equity | 828.00K | 828.00K | 828.00K | 828.00K | 824.80K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -773.00K | 1.34M | 4.04M | 5.00M | 3.98M |
|